Semaglutide and Tirzepatide are often prescribed for individuals with type 2 diabetes who also struggle with obesity. However, specific eligibility criteria, including health conditions and medical history, and BMI are assessed during a consultation with a healthcare provider to determine the suitability of these medications for individual patients.